Cargando…
Aspirin and heparin for the prevention of pre-eclampsia: protocol for a systematic review and network meta-analysis
INTRODUCTION: Pre-eclampsia is an important cause of death and complication for pregnant women and perinatal infant. Low-dose aspirin has been most commonly used to prevent pre-eclampsia in high-risk pregnant women. Recently, heparins have also been used alone or in combination with aspirin to preve...
Autores principales: | Huang, Jinzhu, Chen, Xiaohong, Xing, Haiyan, Chen, Lin, Xie, Zhaolu, He, Shuangshuang, Wang, Xiaofang, Li, Yong, Cui, Huanhuan, Chen, Jianhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443197/ https://www.ncbi.nlm.nih.gov/pubmed/30804037 http://dx.doi.org/10.1136/bmjopen-2018-026920 |
Ejemplares similares
-
Low-dose aspirin for preventing intrauterine growth restriction and pre-eclampsia in sickle cell pregnancy (PIPSICKLE): a randomised controlled trial (study protocol)
por: Afolabi, Bosede Bukola, et al.
Publicado: (2021) -
Trial of feasibility and acceptability of routine low-dose aspirin versus Early Screening Test indicated aspirin for pre-eclampsia prevention (TEST study): a multicentre randomised controlled trial
por: Mone, Fionnuala, et al.
Publicado: (2018) -
Machine learning models for predicting pre-eclampsia: a systematic review protocol
por: Ranjbar, Amene, et al.
Publicado: (2023) -
Postpartum lifestyle interventions among women with pre-eclampsia: a scoping review protocol
por: Haugdahl, Hege Selnes, et al.
Publicado: (2020) -
Cardiovascular and cerebrovascular health after pre-eclampsia: the Motherhealth prospective cohort study protocol
por: Miller, Eliza C, et al.
Publicado: (2021)